COVID-19: Govt panel recommends EUA for Corbevax vaccine for 12-18 age group
Biological E's COVID-19 vaccine Corbevax is administered through intramuscular route with two doses scheduled 28 days apart.
Stay updated with breaking news from Biological E. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biological E's COVID-19 vaccine Corbevax is administered through intramuscular route with two doses scheduled 28 days apart.
Biological-E, Corbevax, COVID-19, Vaccination, covid, vaccine, vaccine for children, DCGI, Drugs Controller General of India, Subject Expert Committee, SEC
Reifman opens up a plethora of relevant issues like the strategic significance and growing strength of the Indo-US relationship
The Drugs Controller General Of India (DCGI) has already approved Corbevax for restricted use in emergency situation among adults on December 28.
Biological E has sought emergency use authorisation from India's drug regulator for its Covid-19 vaccine Corbevax for the 12 to 18 years age group.